How well does the BNT162b2 vaccine protect children and teens against Omicron? - News-Medical.Net

4/3/2022 12:00:00 AM3 years 1 month ago

A study published in the New England Journal of Medicine investigated the vaccine efficiency of the Pfizer BioNTech (BNT162b2) vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant in children and adolescents.

A recent study published in the New England Journal of Medicine investigated the vaccine efficiency of the Pfizer BioNTech (BNT162b2) vaccine against the severe acute respiratory syndrome coronavirus… [+5734 chars]

full article...